{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:17:59Z","timestamp":1787771879823,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.humpath.2016.07.041","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:23Z","timestamp":1479254423000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1098-8799","authenticated-orcid":false,"given":"Alice Muglia Thomaz da","family":"Silva Amancio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Werneck da","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ivanildo","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane da Silva","family":"Quetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirce Maria","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Malagoli","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stenio C\u00e1ssio","family":"Zequi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Leopoldo","family":"Cubilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Paulo","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ademar","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do Perp\u00e9tuo Socorro Saldanha da","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Ven\u00edcio Alves","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1317-2114","authenticated-orcid":false,"given":"Gustavo Cardoso","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2016.07.041_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11912-011-0163-2","article-title":"Penile cancer: epidemiology and treatment","volume":"13","author":"Guimar\u00e3es","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.humpath.2016.07.041_bb0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.humpath.2012.01.014","article-title":"Advances in the pathology of penile carcinomas","volume":"43","author":"Chaux","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/SPC.0000000000000075","article-title":"Managing advanced penile cancer in 2014","volume":"8","author":"Blais","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.humpath.2016.07.041_bb0020","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-5347(01)65471-5","article-title":"Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy","volume":"156","author":"Lopes","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0025","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.juro.2006.06.024","article-title":"Predicting regional lymph node metastasis in Chinese patients with penile squamous cell carcinoma: the role of histopathological classification, tumor stage and depth of invasion","volume":"176","author":"Dai","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/PAS.0b013e31818a01d8","article-title":"Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma: a clinicopathologic and outcome study of 7 patients","volume":"33","author":"Cunha","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0035","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/modpathol.2010.69","article-title":"Warty-basaloid carcinoma: clinicopathological features of a distinctive penile neoplasm. Report of 45 cases","volume":"23","author":"Chaux","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0040","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/01.pas.0000160440.46394.a8","article-title":"Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases","volume":"29","author":"Velazquez","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0045","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.urology.2010.02.038","article-title":"Developments in the pathology of penile squamous cell carcinomas","volume":"76","author":"Chaux","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2016.07.041_bb0050","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.juro.2009.04.028","article-title":"Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases","volume":"182","author":"Guimaraes","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0055","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/PAS.0b013e3181641365","article-title":"Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm","volume":"32","author":"Velazquez","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0060","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/PAS.0b013e31819d17eb","article-title":"The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma","volume":"33","author":"Chaux","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.urology.2006.01.050","article-title":"Front pattern of invasion in squamous cell carcinoma of the penis: new prognostic factor for predicting risk of lymph node metastases","volume":"68","author":"Guimaraes","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2016.07.041_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bju.13071","article-title":"Pattern of invasion is the most important prognostic factor in patients with penile cancer submitted to lymph node dissection and pathological absence of lymph node metastasis","volume":"116","author":"Aita","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2016.07.041_bb0075","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1200\/JCO.2011.34.8367","article-title":"Proof of activity of anti-epidermal growth factor receptor\u2013targeted therapy for relapsed squamous cell carcinoma of the penis","volume":"29","author":"Necchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0080","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","article-title":"Epidermal growth factor receptor\u2013targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis","volume":"113","author":"Carthon","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2016.07.041_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.urology.2013.08.074","article-title":"Epidermal growth factor receptor\u2013targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases","volume":"83","author":"Brown","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2016.07.041_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/CAD.0000000000000024","article-title":"A case of penile squamous cell carcinoma treated with a combination of antiepidermal growth factor receptor antibody and chemotherapy","volume":"25","author":"Men","year":"2014","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.humpath.2016.07.041_bb0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bju.12507","article-title":"Squamous cell carcinoma of the penis: therapeutic targeting of the epidermal growth factor receptor","volume":"113","author":"Minhas","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2016.07.041_bb0100","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","article-title":"Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas","volume":"24","author":"Chung","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0105","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1200\/JCO.2008.21.6796","article-title":"Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer","volume":"27","author":"Laurent-Puig","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0110","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1200\/JCO.2010.31.8923","article-title":"American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non\u2013small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy","volume":"29","author":"Keedy","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3747\/co.v17i1.471","article-title":"EGFR overexpression in squamous cell carcinoma of the penis","volume":"17","author":"Lavens","year":"2010","journal-title":"Curr Oncol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062175","article-title":"Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma","volume":"8","author":"Gou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2016.07.041_bb0125","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.humpath.2013.07.012","article-title":"The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases","volume":"44","author":"Chaux","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017517","article-title":"Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas","volume":"6","author":"Stankiewicz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2016.07.041_bb0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/14728222.2013.783571","article-title":"EGFR mutational status in penile cancer","volume":"17","author":"Di Lorenzo","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.humpath.2016.07.041_bb0140","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1517\/14728222.2013.796172","article-title":"Comment on: EGFR mutational status in Brazilian patients with penile carcinoma","volume":"17","author":"Silva","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.humpath.2016.07.041_bb0145","series-title":"AJCC cancer staging manual","year":"2010"},{"key":"10.1016\/j.humpath.2016.07.041_bb0150","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00428-013-1489-y","article-title":"Detecting EGFR alterations in clinical specimens\u2014pitfalls and necessities","volume":"463","author":"Isaksson","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2016.07.041_bb0155","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.clgc.2016.01.013","article-title":"Epidermal growth factor receptor, excision-repair cross-complementation group 1 protein, and thymidylate synthase expression in penile cancer","volume":"14","author":"Dorff","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2016.07.041_bb0160","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.juro.2007.12.040","article-title":"PIK3CA, HRAS and KRAS gene mutations in human penile cancer","volume":"179","author":"Andersson","year":"2008","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.humpath.2016.07.041_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/annonc\/mdh011","article-title":"Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer","volume":"15","author":"Selvaggi","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2016.07.041_bb0170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lungcan.2008.02.008","article-title":"EGFR FISH versus mutation: different tests, different end-points","volume":"60","author":"Cappuzzo","year":"2008","journal-title":"Lung Cancer"},{"issue":"Suppl. 4","key":"10.1016\/j.humpath.2016.07.041_bb0175","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2016.07.041_bb0180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jnci\/dji112","article-title":"Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non\u2013small-cell lung cancer","volume":"97","author":"Cappuzzo","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2016.07.041_bb0185","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.eururo.2014.05.032","article-title":"Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis","volume":"66","author":"Rieken","year":"2014","journal-title":"Eur Urol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817716303100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817716303100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T23:12:21Z","timestamp":1617837141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817716303100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":37,"alternative-id":["S0046817716303100"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2016.07.041","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2016.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}